Nektar Therapeutics Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31)
Nektar Therapeutics (NKTR) reported Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) of -$226.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss · last filed 2016-02-29
- Nektar Therapeutics available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2015 was -$226.00K.
- Nektar Therapeutics available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2014 was -$95.00K.
- Nektar Therapeutics available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2013 was -$268.00K, a 122.22% decline from fiscal 2012.
- Nektar Therapeutics available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for fiscal 2012 was $1.21M.
| Period end | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 12 month |
|---|---|
| 2015-12-31 | -$226.00K 10-K · filed 2016-02-29 |
| 2014-12-31 | -$95.00K 10-K · filed 2016-02-29 |
| 2013-12-31 | -$268.00K 10-K · filed 2016-02-29 |
| 2012-12-31 | $1.21M 10-K · filed 2015-02-26 |
| 2011-12-31 | -$783.00K 10-K · filed 2014-02-27 |
| 2010-12-31 | -$267.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |